BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Go back to BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS

November 13, 2025 4:09 PM EST

BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

... More